These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15051632)

  • 21. Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats.
    Tsutsui H; Ide T; Hayashidani S; Kinugawa S; Suematsu N; Utsumi H; Takeshita A
    J Cardiovasc Pharmacol; 2001 Jun; 37(6):725-33. PubMed ID: 11392469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure.
    Song YH; Li BS; Chen XM; Cai H
    Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
    Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension.
    Fontana V; Silva PS; Izidoro-Toledo TC; Biagi C; Oliveira EB; Gerlach RF; Tanus-Santos JE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):511-9. PubMed ID: 23085896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.
    Yang Z; Yu X; Cheng L; Miao LY; Li HX; Han LH; Jiang WP
    Arch Cardiovasc Dis; 2013 Apr; 106(4):196-201. PubMed ID: 23706365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between lysosomal cysteine protease cathepsin's activation and left ventricular function and remodeling in hypertensive heart failure rats].
    Cheng XW; Zhang J; Song H; Yang G; Qin XZ; Guan LK; Jin H; Okumura K; Murohara T
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):51-6. PubMed ID: 19099930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension.
    Takenaka H; Kihara Y; Iwanaga Y; Onozawa Y; Toyokuni S; Kita T
    J Mol Cell Cardiol; 2006 Dec; 41(6):989-97. PubMed ID: 16979182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H; Khanal S; Rastogi S; Suzuki G; Imai M; Todor A; Sharov VG; Goldstein S; O'Neill TP; Sabbah HN
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2522-7. PubMed ID: 16428338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM; Robertson SJ; Burns KD; deBlois D
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
    Solomon SD; Skali H; Bourgoun M; Fang J; Ghali JK; Martelet M; Wojciechowski D; Ansmite B; Skards J; Laks T; Henry D; Packer M; Pfeffer MA;
    Am Heart J; 2005 Aug; 150(2):257-62. PubMed ID: 16086927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats.
    Nishikawa N; Masuyama T; Yamamoto K; Sakata Y; Mano T; Miwa T; Sugawara M; Hori M
    J Am Coll Cardiol; 2001 Nov; 38(5):1539-45. PubMed ID: 11691537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
    McElmurray JH; Mukherjee R; New RB; Sampson AC; King MK; Hendrick JW; Goldberg A; Peterson TJ; Hallak H; Zile MR; Spinale FG
    J Pharmacol Exp Ther; 1999 Nov; 291(2):799-811. PubMed ID: 10525103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
    Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
    Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure.
    Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Miwa T; Hori M; Masuyama T
    Hypertension; 2004 Mar; 43(3):686-91. PubMed ID: 14757777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.